Global expenditures on healthcare are approaching seven trillion US dollars a year, or roughly 10 per cent of the world’s gross domestic product. More than 70 per cent of these expenditures occur in North America and Europe alone. Not surprisingly, opportunities are immense and growing in the health and life sciences industry, for businesses that include: pharmaceutical and device manufacturers; research and development organisations; information technology companies; providers; clinicians; insurers and entrepreneurs of every stripe.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Dentons
News from The Lawyer
Briefings from Dentons
The current Markets in Financial Instruments Directive has been replaced by a new Directive and Regulation. This article highlights the major areas of change and the timescales for achieving it.
The Ontario Court of Appeal released its decision last week in Westerhof v Gee Estate and McCallum v Baker, which are the companion cases to Moore v Getahun.
Analysis from The Lawyer
Life in Canada is getting harder for firms as commodities prices fall and work volumes slow
Which firms are cutting it in this era of slimline rosters, and who are the GC new brooms making clean sweeps? The Lawyer can reveal all